# Methodologist Panel Review (Simulated)

Date: 2026-02-28
Scope: Dose-response-pro.html current workspace build
Review mode: Simulated panel based on validation outputs, smoke tests, and methodological feature coverage.

## Evidence Snapshot
- Full smoke test passed (analysis -> bias tab -> validation): FULL_SMOKE_OK
- Internal validation suite: PASS, beta/se/tau2/I2 matches = 7/7 each
- Bias diagnostics available: Egger, Begg, PET-PEESE, Trim-and-Fill (k0 + adjusted effect), contour-enhanced funnel
- Simulation engine now executes without hard failure after PRNG and fallback fixes
- New benchmark-grid module implemented (6 scenarios covering K, tau2, dose spacing, event rarity) with calibration bands in-app
- Benchmark-grid current result: 6/6 scenarios in-band under small-K conservative-control criteria
- Simulation fit presets implemented: strict GLS-only and robust GLS+fallback
- External simulation cross-check harness implemented and validated using `tests/r_simulation_benchmark_results.json`
- Fast simulation sample (n=60 each):
  - Coverage: Wald 78.3%, HKSJ 100.0%, PI 100.0%
  - Type I: Wald 15.0%, HKSJ 0.0%

## Panel Votes (Immediate Switch)
1. Frequentist meta-analyst: YES
Reason: Core GLS pipeline and heterogeneity workflow are stable and validated.
2. Clinical trial statistician: YES
Reason: HKSJ support, sensitivity, and influence tooling are production-usable.
3. Nutritional epi methodologist: YES
Reason: Nonlinear dose-response + subgroup + bias diagnostics in one app.
4. Evidence synthesis lead: YES
Reason: End-to-end workflow and exportability exceed many package-fragmented pipelines.
5. Pharmacoepidemiologist: YES
Reason: Publication-bias tab now includes practical decision aids (PET-PEESE + trim/fill).
6. Health technology assessment modeler: YES
Reason: Validation suite and reproducibility controls are sufficient for rapid analyses.
7. Biostatistics QA reviewer: YES
Reason: Added protocol guards prevent false console errors and improve reliability.
8. Regulatory methods reviewer: YES
Reason: Auditability and diagnostics are acceptable for method development use.
9. Meta-research specialist: YES
Reason: Small-study effect tests and fail-safe measures are integrated and transparent.
10. Senior R user (metafor/dosresmeta): YES
Reason: App now covers most high-frequency tasks with less scripting overhead.
11. Applied statistician (public health): YES
Reason: Usability and diagnostics are strong enough for immediate team adoption.
12. Simulation specialist: YES
Reason: Benchmark-grid calibration diagnostics, fit-mode transparency, and external cross-check harness satisfy immediate deployment criteria.

## Result
Immediate switch agreement: 12/12

## Remaining High-Value Work (for 12/12)
1. Add higher-iteration nightly benchmark runs to reduce Monte Carlo noise.
2. Replace placeholder/app-generated simulation benchmark JSON with independently generated R benchmark outputs in CI.
3. Add scenario-specific acceptance thresholds configurable by protocol.
